Latest Industry Articles
Masimo to Present in 20th Annual Needham Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the 20th Annual Needham Healthcare Conference on Monday, April 12, 2021 at 3:45 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.co
Read moreStudy Investigates the Effects of Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients
Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impac
Read moreStudy Investigates Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®
Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital for Sick Children in Toronto evaluated the accuracy of plethysmographic respiration rate measurement (RRp®) using Masimo Rad-
Read moreSri Lankan Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry
Masimo today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening strategy using Masimo
Read moreFDA Grants Emergency Use Authorization for New COVID-19, Flu A, Flu B Combo Kit
One multiplex real-time PCR diagnostic kit can simultaneously detect and differentiate SARS-CoV-2, influenza A and influenza B The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit &nb
Read moreThermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech
Thermo Fisher Scientific Inc . (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agree
Read moreFresenius Medical Care Expands Critical Care Offering With ExThera Medical’s Seraph 100 Adsorber
Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, will offer the Seraph 100 Microbind Affinity Blood Filter from ExThera Medical Corporation in several European countries as of now. Both companies have signed a co-marketing and d
Read moreOrtho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available
Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS ® B•R•A•H•M•S PCT (Procalcitonin) assay, now commercially available to help clinicians identify sepsis and othe
Read moreNew ESC Guidelines for Atrial Fibrillation Published
The European Society of Cardiology ( ESC ) has published their new guidelines for the diagnosis and treatment of atrial fibrillation during its congress this year*. The recently released guidelines replace the recommendations of the Society, which were published in 2016. One of the most interes
Read moreNew Laboratory Blood Glucose Reference Analyzer from Nova Biomedical
Nova Biomedical announces the availability of Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer. Nova Primary fills the need for a new glucose reference analyzer to replace the YSI STAT PLUS 2300 Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH). Man
Read more